Rapid Chemotherapy-Induced Acute Endothelial Progenitor Cell Mobilization: Implications for Antiangiogenic Drugs as Chemosensitizing Agents

This publication has 47 references indexed in Scilit:

• Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth
  Proceedings of the National Academy of Sciences, 2008
• Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
  New England Journal of Medicine, 2007
• Id1 Restrains p21 Expression to Control Endothelial Progenitor Cell Formation
  PLOS ONE, 2007
• Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy
  Proceedings of the National Academy of Sciences, 2007
• Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
  Nature Biotechnology, 2007
• Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes
  Nature Medicine, 2006
• Analysis of tumor‐associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow‐derived host cells
  The FASEB Journal, 2006
• Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
  Science, 2005
• Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
  Cancer Cell, 2004
• The anti-angiogenic basis of metronomic chemotherapy
  Nature Reviews Cancer, 2004